Market Place
Sourcing Support
All News #Library
Rare Diseases
India Brings Together Rare & Powerful combination of capabilities
13 Apr 2026 //
EXPRESSPHARMA
Servier Gets NICE Nod For Vorasidenib In Low Grade Glioma
31 Mar 2026 //
PHARMIWEB
Servier Sharpens Its Focus On Rare Neurology
12 Jan 2026 //
FIERCE BIOTECH
Servier India Gains CDSCO Nod for Vorasidenib in Grade 2 Glioma
10 Dec 2025 //
EXPRESSPHARMA
Servier`s Voranigo Wins Prix Galien Awards In Multiple Regions
08 Dec 2025 //
PR NEWSWIRE
Servier India Introduces Affordable Biomarker Tests For Rare
12 Nov 2025 //
BUSINESS STD
Servier`s Voranigo Wins 2025 Prix Galien USA Award
31 Oct 2025 //
PR NEWSWIRE
European Commission Approves Servier`s VORANIGO® (vorasidenib)
22 Sep 2025 //
PR NEWSWIRE
Servier Acquires Potential Treatment for Fragile X Syndrome
09 Sep 2025 //
PR NEWSWIRE
Servier Commits up To $530 M Into Eye Cancer Deal with Ideaya
03 Sep 2025 //
PRESS RELEASE
Nicolas Lévy joins Servier as Chief Scientist Rare Diseases
06 May 2022 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.